Abstract
The genome of hepatitis B virus (HBV) encodes two transcriptional activators: the HBx protein and the PreS2-activator large surface protein (LHBs). Both proteins trigger activation of c-Raf-1/MEK kinase cascade. In case of HBx this can be mediated by a PKC-independent and Ras-dependent mechanism, in case of LHBs activation is PKC-dependent and does not require Ras. Selective destruction of either LHBs- or of HBx-specific activation does not result in significant decrease of viral production from transfected HepG2 cells. Simultaneous inhibition of LHBs- and HBx-dependent activation by blocking signaling steps common to both activators, using trans dominant negative c-Raf-1- or MEK-specific inhibitors, abolished HBV gene expression. In accordance with this no HBV propagation was observed after transfection of a mutated HBV genome defective for HBx- and PreS2-activator function. A detailed analysis revealed that the observed inhibition of HBV- propagation is because of a significant reduction of HBV-specific RNA resulting in an inhibition of the de novo synthesis of viral compounds (viral proteins and nucleic acid) and not by blocking secretion or assembly of the virus. Based on these results we conclude that transcriptional-activator function, mediated by the c-Raf-1/MEK signaling cascade, is essential for HBV gene expression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andrisani OM and Barnabas S . (1999). Int. J. Oncol., 15, 373–379.
Benn J and Schneider RJ . (1994). Proc. Natl. Acad. Sci. USA, 91, 10350–10354.
Bouchard M, Wang EH and Schneider RJ . (2001). Science, 294, 2376–2378.
Bruder JT, Heidecker G and Rapp UR . (1992). Genes Dev., 6, 545–556.
Bruss V, Lu R, Thomssen R and Gerlich W . (1994). EMBO J. 13, 2273–2279.
Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H and Gerlich WH . (1984). J. Virol., 52, 396–402.
Hildt E and Hofschneider PH . (1998). Recent Results Cancer Res., 154, 315–329.
Hildt E, Munz B, Saher G, Hofschneider PH . (2002). EMBO J., 21, 525–535.
Hildt E, Munz B, Saher G, Reifenberg K and Hofschneider PH . (2002). EMBO J., 21, 525–535.
Hildt E and Oess S . (1999). J. Exp. Med., 189, 1707–1714.
Hildt E, Saher G, Bruss V and Hofschneider PH . (1996). Virology, 225, 235–239.
Hildt E, Urban S and Hofschneider PH . (1995). Oncogene, 11, 2055–2066.
Kekule AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH and Koshy R . (1990). Nature, 343, 457–461.
Klein NP, Bouchard MJ, Wang LH, Kobarg C and Schneider RJ . (1999). EMBO J., 18, 5019–5027.
Klein NP and Schneider RJ . (1997). Mol. Cell Biol., 17, 6427–6436.
Lucito R, Schneider RJ . (1992). J. Virol., 66, 983–991.
Murakami S, Cheong J, Ohno S, Matsushima K and Kaneko S . (1994). Virology, 199, 243–246.
Oess S and Hildt E . (2000). Gene Ther., 7, 750–758.
Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR and Ludwig S . (2001). Nat. Cell Biol., 3, 301–305.
Sambrook J, Fritsch EF and Maniatis T . (1989). Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Harbour Laboratory Press: Cold Spring Harbour, NY.
Schreck R, Grassman R, Fleckenstein B and Baeuerle PA . (1992). J. Virol., 66, 6288–6293.
Su F and Schneider RJ . (1996). J. Virol., 70, 4558–4566.
Su F, Theodosis CN and Schneider RJ . (2001). J. Virol., 75, 215–225.
Twu JS and Schloemer RH . (1987). J. Virol., 61, 3448–3453.
Weiss L, Kekule A, Jakubowski U, Burgelt E and Hofschneider PH . (1996). Virology, 216, 214–218.
Wollersheim M, Debelka U and Hofschneider PH . (1989). Oncogene, 3, 545–552.
Zoulim F, Saputelli J and Seeger C . (1994). J. Virol., 68, 2026–2030.
Acknowledgements
We thank E Buergelt and S Andric for excellent technical assistance. This work was supported by an RKI-grant to EH.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stöckl, L., Berting, A., Malkowski, B. et al. Integrity of c-Raf-1/MEK signal transduction cascade is essential for hepatitis B virus gene expression. Oncogene 22, 2604–2610 (2003). https://doi.org/10.1038/sj.onc.1206320
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206320
Keywords
This article is cited by
-
The mechanism of TiaoGanYiPi formula for treating chronic hepatitis B by network pharmacology and molecular docking verification
Scientific Reports (2021)
-
HBV infection increases the risk of macular degeneration: the roles of HBx-mediated sensitization of retinal pigment epithelial cells to UV and blue light irradiation
Journal of Translational Medicine (2018)
-
HBx induces HepG-2 cells autophagy through PI3K/Akt–mTOR pathway
Molecular and Cellular Biochemistry (2013)
-
Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review
Digestive Diseases and Sciences (2012)
-
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
Oncogene (2010)